Journal of Thrombosis and Thrombolysis

, Volume 30, Issue 3, pp 378–389

A clinical cardiology perspective of thrombophilias

Article

DOI: 10.1007/s11239-010-0511-3

Cite this article as:
Becker, R.C. J Thromb Thrombolysis (2010) 30: 378. doi:10.1007/s11239-010-0511-3
  • 62 Views

Abstract

Thrombophilias, an inherited and/or acquired predisposition to vascular thrombosis beyond hemostatic needs are common in cardiovascular medicine and include systemic disorders such as coronary atherosclerosis, atrial fibrillation, exogenous obesity, metabolic syndrome, collagen vascular disease, human immunodeficiency virus, blood replacement therapy and several commonly used medications. A contemporary approach to patients with suspected thrombophilias, in addition to a very selective investigation for gain-of-function and loss-of-function gene mutations affecting thromboresistance, must consider prevalent diseases and management decisions encountered regularly by cardiologists in clinical practice. An appropriate recognition of common disease states as thrombophilias will also stimulate platforms for much needed scientific investigation.

Keywords

ThrombophiliaArterial thrombosisCardiovascular disease

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Divisions of Cardiology and HematologyDuke University School of Medicine, Duke Clinical Research InstituteDurhamUSA